Aceragen Inc

Formerly NASDAQ: ACGN

Underwriting Agreements Filter

EX-1.1
from 8-K 39 pages I Idera Pharmaceuticals, Inc. $50,000,000 Common Stock Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 40 pages Idera Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Idera Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 36 pages Idera Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages 6,841,250 Shares of Common Stock and Pre-Funded Warrants to Purchase 2,158,750 Shares of Common Stock Idera Pharmaceuticals, Inc. Purchase Agreement
12/34/56
EX-1.1
from 8-K 37 pages 13,727,251 Shares of Common Stock and Pre-Funded Warrants to Purchase 4,175,975 Shares of Common Stock Idera Pharmaceuticals, Inc. Purchase Agreement
12/34/56
EX-1.1
from S-1/A 36 pages [—] Shares of Common Stock Warrants to Purchase [—] Shares of Common Stock and Warrants to Purchase [—] Shares of Common Stock Idera Pharmaceuticals, Inc. Purchase Agreement
12/34/56
EX-1.1
from S-1/A 35 pages [—] Shares of Common Stock and Warrants to Purchase [—] Shares of Common Stock Idera Pharmaceuticals, Inc. Purchase Agreement
12/34/56
EX-1.1
from 8-K 31 pages Idera Pharmaceuticals, Inc. $10,000,000 Sales Agreement
12/34/56
EX-1.1
from 8-K 15 pages Confidential Louis J. Arcudi III Chief Financial Officer Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge, Ma 02139 Dear Mr. Arcudi
12/34/56
EX-1.1
from 8-K ~20 pages Placement Agency Agreement Dated April 15, 2004
12/34/56
EX-1
from 10-K ~10 pages Underwriting agreement
12/34/56
EX-1
from 8-K ~50 pages Purchase Agreement With Forum Capital Markets L.P.
12/34/56